Hans Hofland, Ph.D.

Articles

Spotlight on Dermira and the QBREXZA story

Hans Hofland, Ph.D.;Steve Xu, MD, MSc, FAAD

January 15th 2020

Hans Hofland, Ph.D, and Dr. Steve Xu shine a spotlight on Dermira and its novel topical medicine indicated for primary axillary hyperhidrosis in patients 9 years of age and older.

Latest Updated Articles

Published: September 19th 2024 | Updated: September 26th 2024

Final Thoughts: The Importance of Comparative Studies in AD

Published: November 17th 2023 | Updated: May 14th 2025

POLL: What Percent of the Global Population is Estimated to Have Hyperhidrosis?

Published: April 9th 2025 | Updated: May 14th 2025

Test Could Help Identify Patients at Risk for Severe Scleroderma

Published: May 9th 2025 | Updated: May 14th 2025

Artax Presents Phase 2a Results of AX-158 for Plaque Psoriasis

Published: February 28th 2025 | Updated: May 14th 2025

POLL: “Lip Flips” or Lip Filler? Analyzing the Latest Trends in Lip Augmentation

Published: January 23rd 2025 | Updated: May 14th 2025

CT-P39 is Just as Effective as Omalizumab for Chronic Spontaneous Urticaria Treatment

Recent Content

Daily Derm Times: May 13, 2025

Tyk2 Inhibition Prevents Islet Inflammation and Delays Type 1 Diabetes Development in Mice

Dual Inhibitor TRIV-509 Shows Promise for Rapid Improvement in Atopic Dermatitis

Botanical-Based Nutraceutical Improves Acne

View More Recent Content

About

Advertise

Job Board

Do Not Sell My Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777